检测新的病毒 | 检测SARS-COV-2和诊断COVID-19 | 检测和监测呼吸道感染 | 检测患者免疫力 | ||
---|---|---|---|---|---|
检测需求 | 宏基因组学 | PCR/qPCR | 扩增子Illumina COVIDSeq检测 | 靶向富集 | 血清学 |
检测速度 | |||||
可扩展且经济高效 | |||||
新病原体的鉴定 | |||||
追踪传播 | |||||
不受突变变化的影响 | |||||
鉴定联合感染和复杂疾病 | |||||
检测抗菌素耐药性 |
充分满足实验室的检测需求
部分满足实验室的检测需求
对给定样本中的所有生物体进行全面测序,鉴定冠状病毒等新型病原体。这种NGS方法有助于加速疫情调查,并支持新实验室检测方法的开发。
检测并鉴定呼吸道病原体和抗菌素耐药性。对致病性呼吸道生物体的通用性检测和抗菌素耐药性标志物可以帮助研究人员检测和监测SARS-CoV-2等呼吸道感染,并优化感染控制策略。
通过识别病原体基因组的特定区域来检测SARS-CoV-2的存在。该方法会使用PCR扩增子的超深度测序来分析目标基因组区域。
合作旨在扩展NGS在临床传染性疾病检测中的应用。在COVID-19大流行期间,两家公司已经加快了合作的进程,以此来为全球开展NGS的客户提供更好的支持,帮助他们进行监测。
阅读文章MiniSeq Rapid reagents reduce sequencing run times to < 5 hours, allowing fast detection of coronaviruses and other respiratory viruses.
阅读应用说明In a groundbreaking initiative, public health labs use Illumina technology to sequence the viral genomes of all positive COVID-19 tests in Australia and track COVID-19 across the country, rather than state by state.
Read ArticleIllumina recently joined the NIH’s Rapid Acceleration of Diagnostics initiative and is offering a COVID testing service to help make SARS-CoV-2 testing more widely available.
Read ArticleA collaborative environment leveraging BaseSpace Correlation Engine helps COVID-19 researchers validate hypotheses around important pathways, biomarkers, and potential drug candidate leads.
Learn More使用多种样本快速制备文库,以无可匹敌的研究灵活性研究编码和非编码转录组。
独立的Illumina Ribo-Zero Plus Kit能去除人、小鼠、大鼠和细菌样本中的核糖体RNA。
能助您探索一系列现有及新兴应用,突破效率,突破极限的开创性台式测序仪。
Comprehensively sequence all organisms present in a given complex sample. Identify novel pathogens or detect microbial abundance in various environments.
Learn MoreSequence exomes or large numbers of genes (e.g. > 50 genes) using a robust hybridization-based enrichment approach that supports a wide range of sample types.
Learn MoreSimultaneously assess a few to hundreds of genes or targets in a single run with this highly targeted multiplex PCR-based sequencing approach.
Learn More